American Century Companies Inc Alnylam Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

A detailed history of American Century Companies Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,592,733 shares of ALNY stock, worth $390 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,592,733
Previous 1,354,169 17.62%
Holding current value
$390 Million
Previous $329 Million 33.14%
% of portfolio
0.26%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $55.8 Million - $68.5 Million
238,564 Added 17.62%
1,592,733 $438 Million
Q2 2024

Aug 07, 2024
SELL
$143.31 - $247.0 $2.79 Million - $4.81 Million
-19,485 Reduced 1.42%
1,354,169 $329 Million
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $140 Million - $190 Million
958,710 Added 231.05%
1,373,654 $205 Million
Q4 2023

Feb 13, 2024
BUY
$151.41 - $196.57 $62.8 Million - $81.6 Million
414,944 New
414,944 $79.4 Million
Q3 2023

Nov 13, 2023
BUY
$170.77 - $211.65 $661,221 - $819,508
3,872 Added 0.88%
442,743 $78.4 Million
Q2 2023

Aug 14, 2023
SELL
$185.01 - $212.05 $1.06 Million - $1.22 Million
-5,737 Reduced 1.29%
438,871 $83.4 Million
Q1 2023

May 11, 2023
SELL
$182.66 - $235.53 $46.6 Million - $60.1 Million
-255,187 Reduced 36.47%
444,608 $89.1 Million
Q4 2022

Feb 13, 2023
BUY
$185.53 - $241.31 $1.26 Million - $1.64 Million
6,788 Added 0.98%
699,795 $166 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $16.4 Million - $27.4 Million
118,066 Added 20.54%
693,007 $139 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $67.1 Million - $94.3 Million
-556,903 Reduced 49.2%
574,941 $83.9 Million
Q1 2022

May 11, 2022
BUY
$127.18 - $173.91 $16.4 Million - $22.5 Million
129,270 Added 12.89%
1,131,844 $185 Million
Q4 2021

Feb 07, 2022
SELL
$159.56 - $209.29 $11 Million - $14.4 Million
-68,897 Reduced 6.43%
1,002,574 $170 Million
Q3 2021

Nov 10, 2021
BUY
$169.75 - $207.73 $4.29 Million - $5.25 Million
25,281 Added 2.42%
1,071,471 $202 Million
Q2 2021

Aug 05, 2021
SELL
$128.63 - $176.89 $6.22 Million - $8.55 Million
-48,331 Reduced 4.42%
1,046,190 $177 Million
Q1 2021

May 14, 2021
BUY
$126.83 - $175.69 $1.92 Million - $2.67 Million
15,171 Added 1.41%
1,094,521 $155 Million
Q4 2020

Feb 12, 2021
BUY
$122.97 - $147.0 $11.1 Million - $13.2 Million
90,038 Added 9.1%
1,079,350 $140 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $954,250 - $1.3 Million
-7,874 Reduced 0.79%
989,312 $144 Million
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $61.5 Million - $92.4 Million
590,558 Added 145.23%
997,186 $148 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $12.2 Million - $17.6 Million
131,148 Added 47.61%
406,628 $44.3 Million
Q4 2019

Feb 12, 2020
SELL
$74.51 - $124.23 $1.35 Million - $2.25 Million
-18,087 Reduced 6.16%
275,480 $31.7 Million
Q3 2019

Nov 13, 2019
SELL
$70.9 - $87.82 $2.77 Million - $3.44 Million
-39,120 Reduced 11.76%
293,567 $23.6 Million
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $24.9 Million - $35.1 Million
-378,163 Reduced 53.2%
332,687 $24.1 Million
Q1 2019

May 14, 2019
BUY
$72.76 - $93.45 $1.29 Million - $1.65 Million
17,687 Added 2.55%
710,850 $0
Q4 2018

Feb 13, 2019
BUY
$62.67 - $88.33 $4.88 Million - $6.88 Million
77,943 Added 12.67%
693,163 $50.5 Million
Q3 2018

Nov 02, 2018
BUY
$87.52 - $122.67 $16.4 Million - $23 Million
187,480 Added 43.83%
615,220 $53.8 Million
Q2 2018

Aug 08, 2018
BUY
$88.31 - $107.8 $37.8 Million - $46.1 Million
427,740 New
427,740 $42.1 Million
Q4 2017

Feb 02, 2018
SELL
$114.49 - $139.98 $711,784 - $870,255
-6,217 Closed
0 $0
Q3 2017

Nov 01, 2017
BUY
$72.53 - $118.27 $450,919 - $735,284
6,217
6,217 $730,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email